Target intelligence / Profile preview

Kelch domain-containing protein 10 (KLHDC10)

Target
KLHDC10
Molecular classification
E3 ubiquitin-protein ligase substrate receptor (adaptor), Component of Cullin-2 RING ligase (CRL2) complex, Kelch-repeat protein, Other
01

Overview

Kelch domain-containing protein 10 (KLHDC10) is a substrate-recognition component of a CRL2 (Cullin-2-RING ligase) E3 ubiquitin ligase complex, involved in selective protein degradation through the DesCEND (destruction via C-end degrons) pathway[2][4][5]. KLHDC10 specifically recognizes short sequence motifs, typically proline-glycine or alanine-rich "CAT tails" at the extreme C-terminus of target proteins and truncated polypeptides, leading to their ubiquitination and subsequent proteasomal degradation[1][2][4][5]. Structurally, KLHDC10 contains a six-bladed β-propeller Kelch domain for substrate recognition, an N-terminal region, and a C-terminal domain mediating interactions with Cullin-2 adaptors[1][2]. It is active in the nucleoplasm and cytoplasm as part of the CRL2-KLHDC10 complex[5]. KLHDC10 helps maintain cellular proteostasis and protein quality control, especially rescuing stalled ribosomes and removing erroneous or aberrant proteins that terminate with certain C-end degrons, but its detailed biological roles and regulation remain subjects of emerging research[1][2][3][5].

Other names
KIAA0265slimscruin like at the midline homolog (Drosophila)PNAS-138PNAS-119scruin like at the midline homologKLHDC10
02

Mechanism of action

Ubiquitin ligase substrate recognition—targets proteins for proteasomal degradation by binding to specific C-terminal degrons (e.g., Ala-tails, Pro-Gly motifs) and directing them to the CRL2 ubiquitin ligase complex[1][2][4][5]

03

Biological functions

Ubiquitin-dependent protein degradationProtein quality controlRescue of stalled ribosomePositive regulation of cellular stress responsesProtein catabolic process via the C-end degron rule pathway
04

Disease associations

Cancer (by analogy with related ubiquitin ligases in degradation of regulatory proteins)Neurodegenerative diseases (potentially, via protein quality control)Postpoliomyelitis syndrome (gene association)Atrial septal defect 5 (gene association)Other
05

Safety considerations

Loss or gain of function could potentially disrupt proteostasis, leading to accumulation of aberrant proteins or excessive protein degradation[1][2][5]

Beyond the preview

Go deeper on Kelch domain-containing protein 10 (KLHDC10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch domain-containing protein 10 (KLHDC10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call